Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection.

MLA

Vollmuth, Yannik, et al. “Comparative Study of Virus and Lymphocyte Distribution with Clinical Data Suggests Early High Dose Immunosuppression as Potential Key Factor for the Therapy of Patients with BoDV-1 Infection.” Emerging Microbes & Infections, vol. 13, no. 1, Dec. 2024, p. 2350168. EBSCOhost, https://doi.org/10.1080/22221751.2024.2350168.

APA

Vollmuth, Y., Jungbäck, N., Mögele, T., Schmidt-Graf, F., Wunderlich, S., Schimmel, M., Rothe, C., Stark, L., Schlegel, J., Rieder, G., Richter, T., Schaller, T., Tappe, D., Märkl, B., Matiasek, K., & Liesche-Starnecker, F. (2024). Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection. Emerging Microbes & Infections, 13(1), 2350168. https://doi.org/10.1080/22221751.2024.2350168

Chicago

Vollmuth, Yannik, Nicola Jungbäck, Tatiana Mögele, Friederike Schmidt-Graf, Silke Wunderlich, Mareike Schimmel, Camilla Rothe, et al. 2024. “Comparative Study of Virus and Lymphocyte Distribution with Clinical Data Suggests Early High Dose Immunosuppression as Potential Key Factor for the Therapy of Patients with BoDV-1 Infection.” Emerging Microbes & Infections 13 (1): 2350168. doi:10.1080/22221751.2024.2350168.